On March 2, 2022, Sanjay S. Subramanian, Chief Financial Officer and Head of Corporate Development of Ocugen, Inc. (the Company), tendered his resignation to the Company, effective as of March 18, 2022 (the Effective Date), in order to pursue new opportunities.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.33 USD | +0.76% | +3.91% | +131.30% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+131.30% | 342M | |
+25.69% | 47.86B | |
+46.90% | 41.42B | |
-3.46% | 40.66B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- OCGN Stock
- News Ocugen, Inc.
- Ocugen, Inc. Announces Resignation of Sanjay S. Subramanian as Chief Financial Officer